92Bio announces strategic alliance with Leveragen
![Leveragen Alliance Featured Photo](https://92biotech.com/wp-content/uploads/2024/03/Leveragen-Singularity.jpg)
92Bio has formed a strategic alliance with Leveragen. This partnership will focus on developing multi-specific antibodies using Leveragen’s industry-leading, fully human single-domain antibody platform known as the Singularity Sapiens Mouse.